The role of candesartan or carvedilol for prevention of anthracycline induced subclinical cardiotoxicity in breast cancer patients.
27 May 2019 (09:00 - 09:06)
Organised by:
Abstract
About the speaker
Daejeon St. Mary's Hospital, Daejeon (Korea (Republic of))
14 More presentations in this session
Professor M. Boehm (Homburg, DE)
Doctor T. Thorvaldsen (Stockholm, SE)
Doctor W. Ouwerkerk (Amsterdam, NL)
Access the full session
The Event
Heart Failure 2019
27 May 2019
09:00 CET
You may be interested in
Congress Session
Congress Session
